Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

Anaes SAQsApplied cardiovascular & respiratory physiology

Anaes SAQs · Applied cardiovascular & respiratory physiology

Pharmacodynamics — receptors and the dose-response relationship

Primary — affinity (Kd/pA2), efficacy (Emax), potency (EC50); graded vs quantal curves; competitive (rightward parallel shift, Emax preserved, pA2) vs irreversible (lower Emax) antagonism; partial agonist (intrinsic activity less than 1, acts as competitive antagonist in presence of full agonist — buprenorphine, aripiprazole); biased agonism (G-protein-biased mu-opioid, carvedilol).

10 marks10 min2 min readVerification in progress

Target exams

ANZCAFRCAABAEDAIC
On this page
Study tools

Target exams

ANZCAFRCAABAEDAIC
Prompt
Define affinity, efficacy and potency, and distinguish a competitive from an irreversible antagonist using the dose-response curve. Explain how a partial agonist can behave as an antagonist, and outline the concept of biased agonism with an anaesthetic example.

Question

Define affinity, efficacy and potency, and distinguish a competitive from an irreversible antagonist using the dose-response curve. Explain how a partial agonist can behave as an antagonist, and outline the concept of biased agonism with an anaesthetic example.

Anaesthesia Pro

Continue reading

You have read the opening of this SAQ. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship library.

Sign in to continueSee pricing
References6ShowHide
  1. [1]Pence A, et al. Competitive interactions between propofol and diazepam at GABA(A) receptors. J Pharmacol Exp Ther, 2022.PMID 36167415
  2. [4]Zhang Y, et al. Autonomic modulation by a G protein-biased mu-opioid receptor agonist. PLoS One, 2026.PMID 42139241
  3. [5]Ji RL, et al. Biosensors for translatable GPCR bias. Trends Pharmacol Sci, 2026.PMID 42285785
  4. [6]Hamed O, et al. The β-Blocker Carvedilol and Related Aryloxypropanolamines Promote ERK1/2 Phosphorylation in HEK293 Cells with K (A) Values Distinct From Their Equilibrium Dissociation Constants as β (2)-Adrenoceptor Antagonists: Evidence for Functional Affinity. J Pharmacol Exp Ther, 2024.PMID 38129128
  5. [7]Edelstein GA, et al. Dopamine antagonist effects of the D2/D3 receptor partial agonist aripiprazole on effort-based choice tasks in male and female rats. Cogn Affect Behav Neurosci, 2026.PMID 40993487
  6. [42285786]Bersten AD, Soni N (eds) Oh's Intensive Care Manual. 8th edition, Elsevier, 2018.
Anaesthesia Pro

$29/ monthor $279 / year

The complete Anaesthesia library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousOxygen delivery and the Fick principleApplied cardiovascular & respiratory physiologyNextPharmacogenetics and variability in drug responseApplied cardiovascular & respiratory physiology